Name:
Sufentanil
Type:
Opioid
AKA:
Sufenta
Sufentanil image
Synthetic substance, no natural derivative
IUPAC Logo
Sufentanil image
Sufentanil, a potent opioid analgesic, was developed in the 1970s by Janssen Pharmaceutica. It is used for its rapid onset and high potency in surgical and intensive care settings. Sufentanil has become an important drug in pain management due to its effectiveness and precision in controlling severe pain.
Synthetic Substances Image
Sufentanil, a potent opioid analgesic, is used for pain management and anesthesia. As a downer, it induces significant sedation and respiratory depression. Short-term effects include pain relief and euphoria, while long-term use can lead to tolerance and dependence. Overdose risks involve severe respiratory depression and potential fatality. Safe dosing requires precise medical supervision. Recent findings focus on its high potency and clinical use in controlled settings.
N/A
Sufentanil, a potent opioid, affects opioid receptors to produce intense euphoria and analgesia. Immediate effects include mood swings and cognitive impairment, with long-term use carrying risks of dependence and severe mental health issues. Research examines its potency and abuse potential.
N/A
Sufentanil, an extremely potent synthetic opioid, is used primarily in surgical settings for pain management. Its potency has made it a critical tool in anesthesiology, but also a substance of concern for potential misuse. Historically, opioids have been central to pain management, from opium use in ancient cultures to modern pharmaceuticals. Sufentanil's use is restricted to medical professionals, but it represents the broader opioid crisis' issues, highlighting the balance between medical necessity and abuse potential. Discussions about sufentanil often intersect with broader debates about opioid prescribing practices and the need for effective pain management solutions.
N/A